About Accuri Cytometers
Accuri Cytometers is a company based in Ann Arbor (United States) founded in 2004 was acquired by Becton Dickinson in February 2011.. Accuri Cytometers has raised $30.91 million across 7 funding rounds from investors including Credit Suisse, BD and Flagship Pioneering. Accuri Cytometers operates in a competitive market with competitors including Cytek Biosciences, ACEA Biosciences, Bioaffinity technologies, NanoFCM and Orflo, among others.
- Headquarter Ann Arbor, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30.91 M (USD)
in 7 rounds
-
Latest Funding Round
$6 M (USD), Series E
Jul 12, 2010
-
Investors
Credit Suisse
& 6 more
-
Employee Count
Employee Count
-
Acquired by
Becton Dickinson
(Feb 07, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Accuri Cytometers
Accuri Cytometers has successfully raised a total of $30.91M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $6 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series E — $6.0M
-
First Round
First Round
(01 Mar 2005)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2010 | Amount | Series E - Accuri Cytometers | Valuation | Arboretum Ventures , InvestMichigan! |
|
| Jul, 2009 | Amount | Series D - Accuri Cytometers | Valuation | InvestMichigan! , Arboretum Ventures | |
| Jul, 2008 | Amount | Series C - Accuri Cytometers | Valuation | F-Prime Capital , Flagship Pioneering |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Accuri Cytometers
Accuri Cytometers has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, BD and Flagship Pioneering. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Founded Year | Domain | Location | |
|
Private equity investments are directed toward US companies.
|
Founded Year | Domain | Location | |
|
Life sciences-focused venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Accuri Cytometers
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Accuri Cytometers
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Accuri Cytometers Comparisons
Competitors of Accuri Cytometers
Accuri Cytometers operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, ACEA Biosciences, Bioaffinity technologies, NanoFCM and Orflo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Advanced flow cytometry systems are manufactured for research applications.
|
|
| domain | founded_year | HQ Location |
Instruments for life science research are developed and marketed.
|
|
| domain | founded_year | HQ Location |
IVD platforms are developed to detect and target cancer cells.
|
|
| domain | founded_year | HQ Location |
Offers advanced tools for nanoparticle analysis in biotechnology and healthcare.
|
|
| domain | founded_year | HQ Location |
Instrumentation for cell and protein analysis is developed and marketed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Accuri Cytometers
Frequently Asked Questions about Accuri Cytometers
When was Accuri Cytometers founded?
Accuri Cytometers was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Where is Accuri Cytometers located?
Accuri Cytometers is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Is Accuri Cytometers a funded company?
Accuri Cytometers is a funded company, having raised a total of $30.91M across 7 funding rounds to date. The company's 1st funding round was a Series C of $13M, raised on Mar 01, 2005.
What does Accuri Cytometers do?
Accuri Cytometers developed Accuri C6 which is used in flow cytometry. Its is a compact and portable device to be used by novice and experienced researchers. The system features an software interface, software templates, and reagent kits that guide users new to flow cytometry through workflows for popular applications. Used in Immunophenotyping, Cell finction analysis, gene expression, non-mammalian studies and DNACell cycle analysis.
Who are the top competitors of Accuri Cytometers?
Accuri Cytometers's top competitors include Cytek Biosciences, Bioaffinity technologies and ACEA Biosciences.
Who are Accuri Cytometers's investors?
Accuri Cytometers has 7 investors. Key investors include Credit Suisse, BD, Flagship Pioneering, Arboretum Ventures, and InvestMichigan!.